These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 28366306)
1. The LargPAD Trial: Phase IIA evaluation of l-arginine infusion in patients with peripheral arterial disease. Kashyap VS; Lakin RO; Campos P; Allemang M; Kim A; Sarac TP; Hausladen A; Stamler JS J Vasc Surg; 2017 Jul; 66(1):187-194. PubMed ID: 28366306 [TBL] [Abstract][Full Text] [Related]
2. In vivo assessment of endothelial function in human lower extremity arteries. Kashyap VS; Lakin RO; Feiten LE; Bishop PD; Sarac TP J Vasc Surg; 2013 Nov; 58(5):1259-66. PubMed ID: 23830159 [TBL] [Abstract][Full Text] [Related]
3. Techniques to harvest diseased human peripheral arteries and measure endothelial function in an ex vivo model. Lakin RO; Zhu W; Feiten L; Kashyap VS J Vasc Surg; 2013 Aug; 58(2):470-7. PubMed ID: 23375603 [TBL] [Abstract][Full Text] [Related]
4. Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral L-arginine supplementation. Hambrecht R; Hilbrich L; Erbs S; Gielen S; Fiehn E; Schoene N; Schuler G J Am Coll Cardiol; 2000 Mar; 35(3):706-13. PubMed ID: 10716474 [TBL] [Abstract][Full Text] [Related]
5. In vivo human lower extremity saphenous vein bypass grafts manifest flow mediated vasodilation. Owens CD; Wake N; Conte MS; Gerhard-Herman M; Beckman JA J Vasc Surg; 2009 Nov; 50(5):1063-70. PubMed ID: 19679424 [TBL] [Abstract][Full Text] [Related]
6. Vasomotor and fibrinolytic responses to kinin receptor agonists in the atherosclerotic human lower limb. Cruden NL; Lang NN; MacGillivray TJ; Uren NG; Fox KA; Newby DE Heart Vessels; 2012 Mar; 27(2):179-85. PubMed ID: 21394642 [TBL] [Abstract][Full Text] [Related]
7. Enhancement of endothelium-dependent vasodilation by low-dose nitroglycerin in patients with congestive heart failure. Schwarz M; Katz SD; Demopoulos L; Hirsch H; Yuen JL; Jondeau G; LeJemtel TH Circulation; 1994 Apr; 89(4):1609-14. PubMed ID: 8149528 [TBL] [Abstract][Full Text] [Related]
8. L-arginine and tetrahydrobiopterin protects against ischemia/reperfusion-induced endothelial dysfunction in patients with type 2 diabetes mellitus and coronary artery disease. Settergren M; Böhm F; Malmström RE; Channon KM; Pernow J Atherosclerosis; 2009 May; 204(1):73-8. PubMed ID: 18849028 [TBL] [Abstract][Full Text] [Related]
9. Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease. Böger RH; Bode-Böger SM; Thiele W; Creutzig A; Alexander K; Frölich JC J Am Coll Cardiol; 1998 Nov; 32(5):1336-44. PubMed ID: 9809945 [TBL] [Abstract][Full Text] [Related]
19. Does acute improvement of endothelial dysfunction in coronary artery disease improve myocardial ischemia? A double-blind comparison of parenteral D- and L-arginine. Quyyumi AA J Am Coll Cardiol; 1998 Oct; 32(4):904-11. PubMed ID: 9768710 [TBL] [Abstract][Full Text] [Related]
20. Muscle α-adrenergic responsiveness during exercise and ATP-induced vasodilation in chronic obstructive pulmonary disease patients. Iepsen UW; Munch GW; Ryrsø CK; Secher NH; Lange P; Thaning P; Pedersen BK; Mortensen SP Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H180-H187. PubMed ID: 29030339 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]